nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—SLC22A11—Conjugated Estrogens—osteoporosis	0.136	0.187	CbGbCtD
Cefazolin—ABCC4—Conjugated Estrogens—osteoporosis	0.126	0.174	CbGbCtD
Cefazolin—SLC22A11—Estradiol—osteoporosis	0.119	0.164	CbGbCtD
Cefazolin—ALB—Estropipate—osteoporosis	0.0989	0.137	CbGbCtD
Cefazolin—SLC22A8—Conjugated Estrogens—osteoporosis	0.0789	0.109	CbGbCtD
Cefazolin—SLC22A8—Estradiol—osteoporosis	0.0692	0.0956	CbGbCtD
Cefazolin—SLC22A6—Conjugated Estrogens—osteoporosis	0.0549	0.0759	CbGbCtD
Cefazolin—ALB—Estradiol—osteoporosis	0.0411	0.0567	CbGbCtD
Cefazolin—ABCC4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00591	0.141	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—WDR1—osteoporosis	0.00119	0.0283	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	0.00113	0.027	CbGpPWpGaD
Cefazolin—ABCC4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000945	0.0226	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—CAP1—osteoporosis	0.000938	0.0224	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	0.000894	0.0213	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—CYP27A1—osteoporosis	0.000802	0.0192	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—CYP27A1—osteoporosis	0.000791	0.0189	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—PLEK—osteoporosis	0.000682	0.0163	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.00065	0.0155	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—TLN1—osteoporosis	0.000588	0.014	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—VCL—osteoporosis	0.00058	0.0138	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.00056	0.0134	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.000552	0.0132	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—WDR1—osteoporosis	0.000537	0.0128	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.000527	0.0126	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	0.000512	0.0122	CbGpPWpGaD
Cefazolin—ALB—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.000511	0.0122	CbGpPWpGaD
Cefazolin—ALB—Lipoprotein metabolism—P4HB—osteoporosis	0.000503	0.012	CbGpPWpGaD
Cefazolin—ALB—Lipid and lipoprotein metabolism—MGLL—osteoporosis	0.000491	0.0117	CbGpPWpGaD
Cefazolin—ABCC4—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.000478	0.0114	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—FGA—osteoporosis	0.000439	0.0105	CbGpPWpGaD
Cefazolin—Anaemia—Risedronate—osteoporosis	0.000439	0.00187	CcSEcCtD
Cefazolin—Anorexia—Calcitriol—osteoporosis	0.000438	0.00187	CcSEcCtD
Cefazolin—Somnolence—Estropipate—osteoporosis	0.000436	0.00186	CcSEcCtD
Cefazolin—Dyspepsia—Estropipate—osteoporosis	0.000431	0.00184	CcSEcCtD
Cefazolin—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000431	0.00184	CcSEcCtD
Cefazolin—Syncope—Risedronate—osteoporosis	0.000426	0.00182	CcSEcCtD
Cefazolin—Dyspepsia—Alendronate—osteoporosis	0.000425	0.00181	CcSEcCtD
Cefazolin—ALB—Platelet degranulation—CAP1—osteoporosis	0.000425	0.0101	CbGpPWpGaD
Cefazolin—Fatigue—Estropipate—osteoporosis	0.000422	0.0018	CcSEcCtD
Cefazolin—TPMT—Biological oxidations—CYP19A1—osteoporosis	0.000422	0.0101	CbGpPWpGaD
Cefazolin—Pain—Estropipate—osteoporosis	0.000419	0.00179	CcSEcCtD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.000419	0.00999	CbGpPWpGaD
Cefazolin—Dyspepsia—Raloxifene—osteoporosis	0.000418	0.00178	CcSEcCtD
Cefazolin—Hypersensitivity—Etidronic acid—osteoporosis	0.000417	0.00178	CcSEcCtD
Cefazolin—Loss of consciousness—Risedronate—osteoporosis	0.000417	0.00178	CcSEcCtD
Cefazolin—Anaemia—Pamidronate—osteoporosis	0.000417	0.00178	CcSEcCtD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000416	0.00994	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—CYP19A1—osteoporosis	0.000416	0.00992	CbGpPWpGaD
Cefazolin—Agitation—Pamidronate—osteoporosis	0.000415	0.00177	CcSEcCtD
Cefazolin—Dyspepsia—Ibandronate—osteoporosis	0.000414	0.00177	CcSEcCtD
Cefazolin—Pain—Alendronate—osteoporosis	0.000413	0.00176	CcSEcCtD
Cefazolin—ALB—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000412	0.00985	CbGpPWpGaD
Cefazolin—Somnolence—Calcitriol—osteoporosis	0.000409	0.00175	CcSEcCtD
Cefazolin—Decreased appetite—Ibandronate—osteoporosis	0.000408	0.00175	CcSEcCtD
Cefazolin—Pain—Raloxifene—osteoporosis	0.000406	0.00173	CcSEcCtD
Cefazolin—Fatigue—Ibandronate—osteoporosis	0.000405	0.00173	CcSEcCtD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	0.000405	0.00966	CbGpPWpGaD
Cefazolin—Syncope—Pamidronate—osteoporosis	0.000405	0.00173	CcSEcCtD
Cefazolin—Leukopenia—Pamidronate—osteoporosis	0.000404	0.00172	CcSEcCtD
Cefazolin—Pain—Ibandronate—osteoporosis	0.000402	0.00172	CcSEcCtD
Cefazolin—Pruritus—Etidronic acid—osteoporosis	0.000401	0.00171	CcSEcCtD
Cefazolin—Gastrointestinal pain—Estropipate—osteoporosis	0.000401	0.00171	CcSEcCtD
Cefazolin—Decreased appetite—Calcitriol—osteoporosis	0.0004	0.00171	CcSEcCtD
Cefazolin—ABCC4—Platelet degranulation—FGB—osteoporosis	0.0004	0.00954	CbGpPWpGaD
Cefazolin—Feeling abnormal—Alendronate—osteoporosis	0.000398	0.0017	CcSEcCtD
Cefazolin—Loss of consciousness—Pamidronate—osteoporosis	0.000396	0.00169	CcSEcCtD
Cefazolin—Gastrointestinal pain—Alendronate—osteoporosis	0.000395	0.00169	CcSEcCtD
Cefazolin—Pain—Calcitriol—osteoporosis	0.000393	0.00168	CcSEcCtD
Cefazolin—Flatulence—Conjugated Estrogens—osteoporosis	0.000391	0.00167	CcSEcCtD
Cefazolin—Convulsion—Pamidronate—osteoporosis	0.000391	0.00167	CcSEcCtD
Cefazolin—Urticaria—Estropipate—osteoporosis	0.000389	0.00166	CcSEcCtD
Cefazolin—Gastrointestinal pain—Raloxifene—osteoporosis	0.000388	0.00166	CcSEcCtD
Cefazolin—Diarrhoea—Etidronic acid—osteoporosis	0.000388	0.00166	CcSEcCtD
Cefazolin—Body temperature increased—Estropipate—osteoporosis	0.000387	0.00165	CcSEcCtD
Cefazolin—Abdominal pain—Estropipate—osteoporosis	0.000387	0.00165	CcSEcCtD
Cefazolin—Feeling abnormal—Ibandronate—osteoporosis	0.000387	0.00165	CcSEcCtD
Cefazolin—Gastrointestinal pain—Ibandronate—osteoporosis	0.000384	0.00164	CcSEcCtD
Cefazolin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A2—osteoporosis	0.000384	0.00917	CbGpPWpGaD
Cefazolin—Urticaria—Alendronate—osteoporosis	0.000383	0.00164	CcSEcCtD
Cefazolin—Abdominal pain—Alendronate—osteoporosis	0.000382	0.00163	CcSEcCtD
Cefazolin—Body temperature increased—Alendronate—osteoporosis	0.000382	0.00163	CcSEcCtD
Cefazolin—Shock—Risedronate—osteoporosis	0.000381	0.00163	CcSEcCtD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.000381	0.00909	CbGpPWpGaD
Cefazolin—Anaemia—Zoledronate—osteoporosis	0.000381	0.00163	CcSEcCtD
Cefazolin—Agitation—Zoledronate—osteoporosis	0.000379	0.00162	CcSEcCtD
Cefazolin—Gastrointestinal pain—Calcitriol—osteoporosis	0.000376	0.00161	CcSEcCtD
Cefazolin—Abdominal pain—Raloxifene—osteoporosis	0.000375	0.0016	CcSEcCtD
Cefazolin—Body temperature increased—Raloxifene—osteoporosis	0.000375	0.0016	CcSEcCtD
Cefazolin—Urticaria—Ibandronate—osteoporosis	0.000373	0.00159	CcSEcCtD
Cefazolin—Abdominal pain—Ibandronate—osteoporosis	0.000371	0.00159	CcSEcCtD
Cefazolin—Body temperature increased—Ibandronate—osteoporosis	0.000371	0.00159	CcSEcCtD
Cefazolin—Confusional state—Pamidronate—osteoporosis	0.000371	0.00159	CcSEcCtD
Cefazolin—Syncope—Zoledronate—osteoporosis	0.000369	0.00158	CcSEcCtD
Cefazolin—Leukopenia—Zoledronate—osteoporosis	0.000369	0.00158	CcSEcCtD
Cefazolin—Anaphylactic shock—Pamidronate—osteoporosis	0.000368	0.00157	CcSEcCtD
Cefazolin—Haemoglobin—Estradiol—osteoporosis	0.000367	0.00157	CcSEcCtD
Cefazolin—Urticaria—Calcitriol—osteoporosis	0.000365	0.00156	CcSEcCtD
Cefazolin—Hepatitis—Estradiol—osteoporosis	0.000365	0.00156	CcSEcCtD
Cefazolin—Haemorrhage—Estradiol—osteoporosis	0.000365	0.00156	CcSEcCtD
Cefazolin—Body temperature increased—Calcitriol—osteoporosis	0.000364	0.00155	CcSEcCtD
Cefazolin—Abdominal pain—Calcitriol—osteoporosis	0.000364	0.00155	CcSEcCtD
Cefazolin—Shock—Pamidronate—osteoporosis	0.000362	0.00155	CcSEcCtD
Cefazolin—Loss of consciousness—Zoledronate—osteoporosis	0.000362	0.00155	CcSEcCtD
Cefazolin—Hypersensitivity—Estropipate—osteoporosis	0.000361	0.00154	CcSEcCtD
Cefazolin—Thrombocytopenia—Pamidronate—osteoporosis	0.00036	0.00154	CcSEcCtD
Cefazolin—Vomiting—Etidronic acid—osteoporosis	0.00036	0.00154	CcSEcCtD
Cefazolin—Rash—Etidronic acid—osteoporosis	0.000357	0.00153	CcSEcCtD
Cefazolin—Convulsion—Zoledronate—osteoporosis	0.000357	0.00153	CcSEcCtD
Cefazolin—Dermatitis—Etidronic acid—osteoporosis	0.000357	0.00152	CcSEcCtD
Cefazolin—Syncope—Conjugated Estrogens—osteoporosis	0.000356	0.00152	CcSEcCtD
Cefazolin—Hypersensitivity—Alendronate—osteoporosis	0.000356	0.00152	CcSEcCtD
Cefazolin—Headache—Etidronic acid—osteoporosis	0.000355	0.00152	CcSEcCtD
Cefazolin—Asthenia—Estropipate—osteoporosis	0.000352	0.0015	CcSEcCtD
Cefazolin—Anorexia—Pamidronate—osteoporosis	0.000351	0.0015	CcSEcCtD
Cefazolin—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000349	0.00149	CcSEcCtD
Cefazolin—Pruritus—Estropipate—osteoporosis	0.000347	0.00148	CcSEcCtD
Cefazolin—Asthenia—Alendronate—osteoporosis	0.000346	0.00148	CcSEcCtD
Cefazolin—Hypersensitivity—Ibandronate—osteoporosis	0.000346	0.00148	CcSEcCtD
Cefazolin—Erythema multiforme—Estradiol—osteoporosis	0.000345	0.00147	CcSEcCtD
Cefazolin—Hypotension—Pamidronate—osteoporosis	0.000344	0.00147	CcSEcCtD
Cefazolin—Convulsion—Conjugated Estrogens—osteoporosis	0.000344	0.00147	CcSEcCtD
Cefazolin—Fatigue—Ethinyl Estradiol—osteoporosis	0.000342	0.00146	CcSEcCtD
Cefazolin—Pruritus—Alendronate—osteoporosis	0.000341	0.00146	CcSEcCtD
Cefazolin—Dyspepsia—Risedronate—osteoporosis	0.000341	0.00146	CcSEcCtD
Cefazolin—Confusional state—Zoledronate—osteoporosis	0.000339	0.00145	CcSEcCtD
Cefazolin—Hypersensitivity—Calcitriol—osteoporosis	0.000339	0.00145	CcSEcCtD
Cefazolin—Asthenia—Ibandronate—osteoporosis	0.000337	0.00144	CcSEcCtD
Cefazolin—Nausea—Etidronic acid—osteoporosis	0.000336	0.00144	CcSEcCtD
Cefazolin—Anaphylactic shock—Zoledronate—osteoporosis	0.000336	0.00144	CcSEcCtD
Cefazolin—Diarrhoea—Estropipate—osteoporosis	0.000335	0.00143	CcSEcCtD
Cefazolin—ALB—Lipid and lipoprotein metabolism—P4HB—osteoporosis	0.000334	0.00797	CbGpPWpGaD
Cefazolin—Fatigue—Risedronate—osteoporosis	0.000334	0.00143	CcSEcCtD
Cefazolin—Pruritus—Ibandronate—osteoporosis	0.000332	0.00142	CcSEcCtD
Cefazolin—Pain—Risedronate—osteoporosis	0.000331	0.00141	CcSEcCtD
Cefazolin—Shock—Zoledronate—osteoporosis	0.000331	0.00141	CcSEcCtD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.000331	0.00789	CbGpPWpGaD
Cefazolin—Diarrhoea—Alendronate—osteoporosis	0.00033	0.00141	CcSEcCtD
Cefazolin—Asthenia—Calcitriol—osteoporosis	0.00033	0.00141	CcSEcCtD
Cefazolin—Thrombocytopenia—Zoledronate—osteoporosis	0.000329	0.00141	CcSEcCtD
Cefazolin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000327	0.0014	CcSEcCtD
Cefazolin—Somnolence—Pamidronate—osteoporosis	0.000327	0.0014	CcSEcCtD
Cefazolin—Pruritus—Calcitriol—osteoporosis	0.000325	0.00139	CcSEcCtD
Cefazolin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000325	0.00139	CcSEcCtD
Cefazolin—Diarrhoea—Raloxifene—osteoporosis	0.000325	0.00139	CcSEcCtD
Cefazolin—Dyspepsia—Pamidronate—osteoporosis	0.000324	0.00138	CcSEcCtD
Cefazolin—Dizziness—Estropipate—osteoporosis	0.000324	0.00138	CcSEcCtD
Cefazolin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000324	0.00138	CcSEcCtD
Cefazolin—Diarrhoea—Ibandronate—osteoporosis	0.000322	0.00137	CcSEcCtD
Cefazolin—Anorexia—Zoledronate—osteoporosis	0.000321	0.00137	CcSEcCtD
Cefazolin—Decreased appetite—Pamidronate—osteoporosis	0.00032	0.00137	CcSEcCtD
Cefazolin—Dizziness—Alendronate—osteoporosis	0.000319	0.00136	CcSEcCtD
Cefazolin—Shock—Conjugated Estrogens—osteoporosis	0.000319	0.00136	CcSEcCtD
Cefazolin—Fatigue—Pamidronate—osteoporosis	0.000317	0.00136	CcSEcCtD
Cefazolin—Gastrointestinal pain—Risedronate—osteoporosis	0.000317	0.00135	CcSEcCtD
Cefazolin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000316	0.00135	CcSEcCtD
Cefazolin—Pain—Pamidronate—osteoporosis	0.000315	0.00134	CcSEcCtD
Cefazolin—Diarrhoea—Calcitriol—osteoporosis	0.000315	0.00134	CcSEcCtD
Cefazolin—Hypotension—Zoledronate—osteoporosis	0.000314	0.00134	CcSEcCtD
Cefazolin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000314	0.00134	CcSEcCtD
Cefazolin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000314	0.00134	CcSEcCtD
Cefazolin—Dizziness—Raloxifene—osteoporosis	0.000314	0.00134	CcSEcCtD
Cefazolin—Flatulence—Estradiol—osteoporosis	0.000313	0.00134	CcSEcCtD
Cefazolin—Vomiting—Estropipate—osteoporosis	0.000312	0.00133	CcSEcCtD
Cefazolin—Dizziness—Ibandronate—osteoporosis	0.000311	0.00133	CcSEcCtD
Cefazolin—ABCC4—Ectoderm Differentiation—TNFRSF11B—osteoporosis	0.000311	0.00741	CbGpPWpGaD
Cefazolin—Rash—Estropipate—osteoporosis	0.000309	0.00132	CcSEcCtD
Cefazolin—Dermatitis—Estropipate—osteoporosis	0.000309	0.00132	CcSEcCtD
Cefazolin—Anorexia—Conjugated Estrogens—osteoporosis	0.000309	0.00132	CcSEcCtD
Cefazolin—ALB—Platelet degranulation—PLEK—osteoporosis	0.000309	0.00737	CbGpPWpGaD
Cefazolin—Urticaria—Risedronate—osteoporosis	0.000308	0.00131	CcSEcCtD
Cefazolin—Headache—Estropipate—osteoporosis	0.000307	0.00131	CcSEcCtD
Cefazolin—Vomiting—Alendronate—osteoporosis	0.000307	0.00131	CcSEcCtD
Cefazolin—Abdominal pain—Risedronate—osteoporosis	0.000306	0.00131	CcSEcCtD
Cefazolin—Body temperature increased—Risedronate—osteoporosis	0.000306	0.00131	CcSEcCtD
Cefazolin—ABCC4—Ectoderm Differentiation—NFATC1—osteoporosis	0.000306	0.00729	CbGpPWpGaD
Cefazolin—Rash—Alendronate—osteoporosis	0.000304	0.0013	CcSEcCtD
Cefazolin—Dermatitis—Alendronate—osteoporosis	0.000304	0.0013	CcSEcCtD
Cefazolin—Feeling abnormal—Pamidronate—osteoporosis	0.000303	0.0013	CcSEcCtD
Cefazolin—Hypotension—Conjugated Estrogens—osteoporosis	0.000303	0.00129	CcSEcCtD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.000302	0.00722	CbGpPWpGaD
Cefazolin—Headache—Alendronate—osteoporosis	0.000302	0.00129	CcSEcCtD
Cefazolin—Vomiting—Raloxifene—osteoporosis	0.000302	0.00129	CcSEcCtD
Cefazolin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000301	0.00129	CcSEcCtD
Cefazolin—Rash—Raloxifene—osteoporosis	0.000299	0.00128	CcSEcCtD
Cefazolin—Dermatitis—Raloxifene—osteoporosis	0.000299	0.00128	CcSEcCtD
Cefazolin—Somnolence—Zoledronate—osteoporosis	0.000299	0.00128	CcSEcCtD
Cefazolin—Vomiting—Ibandronate—osteoporosis	0.000299	0.00128	CcSEcCtD
Cefazolin—Headache—Raloxifene—osteoporosis	0.000297	0.00127	CcSEcCtD
Cefazolin—Rash—Ibandronate—osteoporosis	0.000296	0.00127	CcSEcCtD
Cefazolin—Dermatitis—Ibandronate—osteoporosis	0.000296	0.00126	CcSEcCtD
Cefazolin—Dyspepsia—Zoledronate—osteoporosis	0.000296	0.00126	CcSEcCtD
Cefazolin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—osteoporosis	0.000295	0.00705	CbGpPWpGaD
Cefazolin—Headache—Ibandronate—osteoporosis	0.000294	0.00126	CcSEcCtD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.000294	0.00702	CbGpPWpGaD
Cefazolin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000293	0.00125	CcSEcCtD
Cefazolin—Vomiting—Calcitriol—osteoporosis	0.000292	0.00125	CcSEcCtD
Cefazolin—Decreased appetite—Zoledronate—osteoporosis	0.000292	0.00125	CcSEcCtD
Cefazolin—ABCC4—Ectoderm Differentiation—WNT1—osteoporosis	0.000292	0.00697	CbGpPWpGaD
Cefazolin—Agitation—Estradiol—osteoporosis	0.000292	0.00125	CcSEcCtD
Cefazolin—Nausea—Estropipate—osteoporosis	0.000291	0.00124	CcSEcCtD
Cefazolin—Abdominal pain—Pamidronate—osteoporosis	0.000291	0.00124	CcSEcCtD
Cefazolin—Body temperature increased—Pamidronate—osteoporosis	0.000291	0.00124	CcSEcCtD
Cefazolin—Rash—Calcitriol—osteoporosis	0.00029	0.00124	CcSEcCtD
Cefazolin—Fatigue—Zoledronate—osteoporosis	0.00029	0.00124	CcSEcCtD
Cefazolin—Dermatitis—Calcitriol—osteoporosis	0.00029	0.00124	CcSEcCtD
Cefazolin—Headache—Calcitriol—osteoporosis	0.000288	0.00123	CcSEcCtD
Cefazolin—Somnolence—Conjugated Estrogens—osteoporosis	0.000288	0.00123	CcSEcCtD
Cefazolin—Pain—Zoledronate—osteoporosis	0.000288	0.00123	CcSEcCtD
Cefazolin—Nausea—Alendronate—osteoporosis	0.000287	0.00122	CcSEcCtD
Cefazolin—Hypersensitivity—Risedronate—osteoporosis	0.000285	0.00122	CcSEcCtD
Cefazolin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000285	0.00122	CcSEcCtD
Cefazolin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000285	0.00122	CcSEcCtD
Cefazolin—Syncope—Estradiol—osteoporosis	0.000285	0.00122	CcSEcCtD
Cefazolin—Nausea—Raloxifene—osteoporosis	0.000282	0.0012	CcSEcCtD
Cefazolin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000281	0.0012	CcSEcCtD
Cefazolin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000281	0.0012	CcSEcCtD
Cefazolin—Fatigue—Conjugated Estrogens—osteoporosis	0.000279	0.00119	CcSEcCtD
Cefazolin—Nausea—Ibandronate—osteoporosis	0.000279	0.00119	CcSEcCtD
Cefazolin—Loss of consciousness—Estradiol—osteoporosis	0.000279	0.00119	CcSEcCtD
Cefazolin—Asthenia—Risedronate—osteoporosis	0.000278	0.00119	CcSEcCtD
Cefazolin—Feeling abnormal—Zoledronate—osteoporosis	0.000277	0.00118	CcSEcCtD
Cefazolin—Pain—Conjugated Estrogens—osteoporosis	0.000277	0.00118	CcSEcCtD
Cefazolin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000275	0.00117	CcSEcCtD
Cefazolin—Pruritus—Risedronate—osteoporosis	0.000274	0.00117	CcSEcCtD
Cefazolin—Nausea—Calcitriol—osteoporosis	0.000273	0.00117	CcSEcCtD
Cefazolin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000272	0.00116	CcSEcCtD
Cefazolin—ABCC4—Hemostasis—WDR1—osteoporosis	0.000271	0.00648	CbGpPWpGaD
Cefazolin—Hypersensitivity—Pamidronate—osteoporosis	0.000271	0.00116	CcSEcCtD
Cefazolin—Urticaria—Zoledronate—osteoporosis	0.000267	0.00114	CcSEcCtD
Cefazolin—ALB—Platelet degranulation—TLN1—osteoporosis	0.000266	0.00635	CbGpPWpGaD
Cefazolin—Abdominal pain—Zoledronate—osteoporosis	0.000266	0.00114	CcSEcCtD
Cefazolin—Body temperature increased—Zoledronate—osteoporosis	0.000266	0.00114	CcSEcCtD
Cefazolin—Diarrhoea—Risedronate—osteoporosis	0.000265	0.00113	CcSEcCtD
Cefazolin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000265	0.00113	CcSEcCtD
Cefazolin—Asthenia—Pamidronate—osteoporosis	0.000264	0.00113	CcSEcCtD
Cefazolin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000263	0.00112	CcSEcCtD
Cefazolin—ALB—Platelet degranulation—VCL—osteoporosis	0.000262	0.00626	CbGpPWpGaD
Cefazolin—Confusional state—Estradiol—osteoporosis	0.000261	0.00112	CcSEcCtD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000261	0.00622	CbGpPWpGaD
Cefazolin—Pruritus—Pamidronate—osteoporosis	0.00026	0.00111	CcSEcCtD
Cefazolin—Anaphylactic shock—Estradiol—osteoporosis	0.000259	0.00111	CcSEcCtD
Cefazolin—Urticaria—Conjugated Estrogens—osteoporosis	0.000257	0.0011	CcSEcCtD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000257	0.00614	CbGpPWpGaD
Cefazolin—Dizziness—Risedronate—osteoporosis	0.000256	0.00109	CcSEcCtD
Cefazolin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000256	0.00109	CcSEcCtD
Cefazolin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000256	0.00109	CcSEcCtD
Cefazolin—Shock—Estradiol—osteoporosis	0.000255	0.00109	CcSEcCtD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.000253	0.00605	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—POMC—osteoporosis	0.000253	0.00605	CbGpPWpGaD
Cefazolin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000253	0.00108	CcSEcCtD
Cefazolin—Diarrhoea—Pamidronate—osteoporosis	0.000252	0.00108	CcSEcCtD
Cefazolin—Rash—Ethinyl Estradiol—osteoporosis	0.00025	0.00107	CcSEcCtD
Cefazolin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00025	0.00107	CcSEcCtD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.00025	0.00597	CbGpPWpGaD
Cefazolin—Headache—Ethinyl Estradiol—osteoporosis	0.000249	0.00106	CcSEcCtD
Cefazolin—Hypersensitivity—Zoledronate—osteoporosis	0.000248	0.00106	CcSEcCtD
Cefazolin—Vomiting—Risedronate—osteoporosis	0.000246	0.00105	CcSEcCtD
Cefazolin—Rash—Risedronate—osteoporosis	0.000244	0.00104	CcSEcCtD
Cefazolin—Dermatitis—Risedronate—osteoporosis	0.000244	0.00104	CcSEcCtD
Cefazolin—Dizziness—Pamidronate—osteoporosis	0.000243	0.00104	CcSEcCtD
Cefazolin—Headache—Risedronate—osteoporosis	0.000243	0.00104	CcSEcCtD
Cefazolin—Asthenia—Zoledronate—osteoporosis	0.000241	0.00103	CcSEcCtD
Cefazolin—TPMT—Metabolism—FDPS—osteoporosis	0.000239	0.0057	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PKM—osteoporosis	0.000239	0.0057	CbGpPWpGaD
Cefazolin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000239	0.00102	CcSEcCtD
Cefazolin—ALB—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.000238	0.00569	CbGpPWpGaD
Cefazolin—Pruritus—Zoledronate—osteoporosis	0.000238	0.00102	CcSEcCtD
Cefazolin—Nausea—Ethinyl Estradiol—osteoporosis	0.000236	0.00101	CcSEcCtD
Cefazolin—Vomiting—Pamidronate—osteoporosis	0.000234	0.001	CcSEcCtD
Cefazolin—Asthenia—Conjugated Estrogens—osteoporosis	0.000232	0.000992	CcSEcCtD
Cefazolin—Rash—Pamidronate—osteoporosis	0.000232	0.000992	CcSEcCtD
Cefazolin—Dermatitis—Pamidronate—osteoporosis	0.000232	0.000991	CcSEcCtD
Cefazolin—Headache—Pamidronate—osteoporosis	0.000231	0.000985	CcSEcCtD
Cefazolin—Somnolence—Estradiol—osteoporosis	0.00023	0.000984	CcSEcCtD
Cefazolin—Diarrhoea—Zoledronate—osteoporosis	0.00023	0.000983	CcSEcCtD
Cefazolin—Nausea—Risedronate—osteoporosis	0.00023	0.000983	CcSEcCtD
Cefazolin—Pruritus—Conjugated Estrogens—osteoporosis	0.000229	0.000979	CcSEcCtD
Cefazolin—Dyspepsia—Estradiol—osteoporosis	0.000228	0.000974	CcSEcCtD
Cefazolin—TPMT—Metabolism—PGLS—osteoporosis	0.000227	0.00541	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GPD2—osteoporosis	0.000227	0.00541	CbGpPWpGaD
Cefazolin—Decreased appetite—Estradiol—osteoporosis	0.000225	0.000962	CcSEcCtD
Cefazolin—Fatigue—Estradiol—osteoporosis	0.000223	0.000954	CcSEcCtD
Cefazolin—Dizziness—Zoledronate—osteoporosis	0.000222	0.00095	CcSEcCtD
Cefazolin—Pain—Estradiol—osteoporosis	0.000222	0.000947	CcSEcCtD
Cefazolin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000222	0.000946	CcSEcCtD
Cefazolin—Nausea—Pamidronate—osteoporosis	0.000219	0.000934	CcSEcCtD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000215	0.00513	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CAP1—osteoporosis	0.000215	0.00512	CbGpPWpGaD
Cefazolin—Dizziness—Conjugated Estrogens—osteoporosis	0.000214	0.000915	CcSEcCtD
Cefazolin—Vomiting—Zoledronate—osteoporosis	0.000214	0.000913	CcSEcCtD
Cefazolin—Feeling abnormal—Estradiol—osteoporosis	0.000214	0.000912	CcSEcCtD
Cefazolin—Rash—Zoledronate—osteoporosis	0.000212	0.000906	CcSEcCtD
Cefazolin—Gastrointestinal pain—Estradiol—osteoporosis	0.000212	0.000905	CcSEcCtD
Cefazolin—Dermatitis—Zoledronate—osteoporosis	0.000212	0.000905	CcSEcCtD
Cefazolin—Headache—Zoledronate—osteoporosis	0.000211	0.0009	CcSEcCtD
Cefazolin—TPMT—Metabolism—ATIC—osteoporosis	0.000207	0.00494	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PNP—osteoporosis	0.000207	0.00494	CbGpPWpGaD
Cefazolin—Vomiting—Conjugated Estrogens—osteoporosis	0.000206	0.000879	CcSEcCtD
Cefazolin—Urticaria—Estradiol—osteoporosis	0.000206	0.000879	CcSEcCtD
Cefazolin—Abdominal pain—Estradiol—osteoporosis	0.000205	0.000875	CcSEcCtD
Cefazolin—Body temperature increased—Estradiol—osteoporosis	0.000205	0.000875	CcSEcCtD
Cefazolin—Rash—Conjugated Estrogens—osteoporosis	0.000204	0.000872	CcSEcCtD
Cefazolin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000204	0.000871	CcSEcCtD
Cefazolin—Headache—Conjugated Estrogens—osteoporosis	0.000203	0.000867	CcSEcCtD
Cefazolin—Nausea—Zoledronate—osteoporosis	0.0002	0.000853	CcSEcCtD
Cefazolin—ALB—Platelet degranulation—FGA—osteoporosis	0.000199	0.00475	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000195	0.00465	CbGpPWpGaD
Cefazolin—Nausea—Conjugated Estrogens—osteoporosis	0.000192	0.000822	CcSEcCtD
Cefazolin—Hypersensitivity—Estradiol—osteoporosis	0.000191	0.000816	CcSEcCtD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.000189	0.00452	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000188	0.0045	CbGpPWpGaD
Cefazolin—Asthenia—Estradiol—osteoporosis	0.000186	0.000794	CcSEcCtD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000185	0.00441	CbGpPWpGaD
Cefazolin—Pruritus—Estradiol—osteoporosis	0.000183	0.000783	CcSEcCtD
Cefazolin—ABCC4—Platelet degranulation—IGF1—osteoporosis	0.000181	0.00432	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—FGB—osteoporosis	0.000181	0.00432	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000177	0.00423	CbGpPWpGaD
Cefazolin—Diarrhoea—Estradiol—osteoporosis	0.000177	0.000757	CcSEcCtD
Cefazolin—TPMT—Metabolism—OXCT1—osteoporosis	0.000176	0.0042	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CA2—osteoporosis	0.000176	0.0042	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—SOD2—osteoporosis	0.000173	0.00414	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.000172	0.00412	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.000172	0.00411	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—MGLL—osteoporosis	0.000172	0.0041	CbGpPWpGaD
Cefazolin—Dizziness—Estradiol—osteoporosis	0.000171	0.000732	CcSEcCtD
Cefazolin—ABCC4—Hemostasis—MGLL—osteoporosis	0.00017	0.00407	CbGpPWpGaD
Cefazolin—Vomiting—Estradiol—osteoporosis	0.000165	0.000704	CcSEcCtD
Cefazolin—Rash—Estradiol—osteoporosis	0.000163	0.000698	CcSEcCtD
Cefazolin—Dermatitis—Estradiol—osteoporosis	0.000163	0.000697	CcSEcCtD
Cefazolin—Headache—Estradiol—osteoporosis	0.000162	0.000694	CcSEcCtD
Cefazolin—ABCC4—NRF2 pathway—AGER—osteoporosis	0.000159	0.00379	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PLEK—osteoporosis	0.000156	0.00372	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ANXA2—osteoporosis	0.000156	0.00372	CbGpPWpGaD
Cefazolin—Nausea—Estradiol—osteoporosis	0.000154	0.000658	CcSEcCtD
Cefazolin—ALB—Vitamin B12 Metabolism—MTHFR—osteoporosis	0.000153	0.00364	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.00015	0.00357	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—IDH2—osteoporosis	0.000146	0.00348	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—SOD2—osteoporosis	0.000141	0.00337	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000141	0.00336	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP27A1—osteoporosis	0.000137	0.00328	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.000137	0.00327	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000135	0.00322	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—GPX1—osteoporosis	0.000135	0.00321	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TLN1—osteoporosis	0.000134	0.00321	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ACP5—osteoporosis	0.000133	0.00319	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—VCL—osteoporosis	0.000133	0.00316	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—MTHFR—osteoporosis	0.000124	0.00296	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—TPI1—osteoporosis	0.000124	0.00296	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—WDR1—osteoporosis	0.000123	0.00293	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000118	0.00282	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000117	0.0028	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—P4HB—osteoporosis	0.000117	0.00279	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000116	0.00278	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GAPDH—osteoporosis	0.000115	0.00273	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	0.000112	0.00267	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—RAP1A—osteoporosis	0.000112	0.00266	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—RAP1A—osteoporosis	0.000111	0.00264	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—TGFB1—osteoporosis	0.000109	0.00259	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	0.000107	0.00255	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	0.000103	0.00247	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—FGA—osteoporosis	0.0001	0.0024	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	9.86e-05	0.00235	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	9.77e-05	0.00233	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	9.72e-05	0.00232	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CAP1—osteoporosis	9.71e-05	0.00232	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	9.27e-05	0.00221	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—FGB—osteoporosis	9.14e-05	0.00218	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	9.06e-05	0.00216	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ENO1—osteoporosis	9.02e-05	0.00215	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PSMA2—osteoporosis	8.89e-05	0.00212	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PSMA5—osteoporosis	8.89e-05	0.00212	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	8.82e-05	0.00211	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—IGF1—osteoporosis	8.19e-05	0.00195	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—IGF1—osteoporosis	8.03e-05	0.00192	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	8.02e-05	0.00192	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	7.8e-05	0.00186	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MGLL—osteoporosis	7.71e-05	0.00184	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL1B—osteoporosis	7.37e-05	0.00176	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP19A1—osteoporosis	7.21e-05	0.00172	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.21e-05	0.00172	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PLEK—osteoporosis	7.05e-05	0.00168	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ANXA2—osteoporosis	7.05e-05	0.00168	CbGpPWpGaD
Cefazolin—ABCC4—Ectoderm Differentiation—MYC—osteoporosis	7.03e-05	0.00168	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7.02e-05	0.00168	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.92e-05	0.00165	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—TGFB1—osteoporosis	6.71e-05	0.0016	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	6.57e-05	0.00157	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	6.11e-05	0.00146	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TLN1—osteoporosis	6.08e-05	0.00145	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—VCL—osteoporosis	6e-05	0.00143	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ADCY5—osteoporosis	5.89e-05	0.00141	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GPX1—osteoporosis	5.87e-05	0.0014	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	5.85e-05	0.0014	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.61e-05	0.00134	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—MTHFR—osteoporosis	5.42e-05	0.00129	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TNF—osteoporosis	5.35e-05	0.00128	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	5.3e-05	0.00127	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.28e-05	0.00126	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.06e-05	0.00121	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—RAP1A—osteoporosis	5.01e-05	0.0012	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—TGFB1—osteoporosis	4.91e-05	0.00117	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	4.81e-05	0.00115	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.77e-05	0.00114	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	4.68e-05	0.00112	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—FGA—osteoporosis	4.55e-05	0.00109	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.41e-05	0.00105	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PKM—osteoporosis	4.35e-05	0.00104	CbGpPWpGaD
Cefazolin—ALB—Metabolism—FDPS—osteoporosis	4.35e-05	0.00104	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—POMC—osteoporosis	4.33e-05	0.00103	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL6—osteoporosis	4.32e-05	0.00103	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—TNF—osteoporosis	4.25e-05	0.00101	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IGF1—osteoporosis	4.14e-05	0.000988	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—FGB—osteoporosis	4.14e-05	0.000987	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GPD2—osteoporosis	4.13e-05	0.000985	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PGLS—osteoporosis	4.13e-05	0.000985	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ATIC—osteoporosis	3.77e-05	0.000901	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PNP—osteoporosis	3.77e-05	0.000901	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	3.63e-05	0.000867	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL6—osteoporosis	3.43e-05	0.000818	CbGpPWpGaD
Cefazolin—ALB—Metabolism—OXCT1—osteoporosis	3.21e-05	0.000766	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CA2—osteoporosis	3.21e-05	0.000766	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MGLL—osteoporosis	3.13e-05	0.000747	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.95e-05	0.000704	CbGpPWpGaD
Cefazolin—ALB—Metabolism—IDH2—osteoporosis	2.66e-05	0.000635	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP27A1—osteoporosis	2.5e-05	0.000597	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TGFB1—osteoporosis	2.48e-05	0.000592	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ACP5—osteoporosis	2.43e-05	0.000581	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.4e-05	0.000573	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.29e-05	0.000547	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TPI1—osteoporosis	2.26e-05	0.00054	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	2.18e-05	0.00052	CbGpPWpGaD
Cefazolin—ALB—Metabolism—P4HB—osteoporosis	2.13e-05	0.000507	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GAPDH—osteoporosis	2.09e-05	0.000498	CbGpPWpGaD
Cefazolin—ALB—Metabolism—RAP1A—osteoporosis	2.03e-05	0.000485	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IGF1—osteoporosis	1.87e-05	0.000447	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.77e-05	0.000423	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ENO1—osteoporosis	1.64e-05	0.000392	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PSMA5—osteoporosis	1.62e-05	0.000386	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PSMA2—osteoporosis	1.62e-05	0.000386	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP19A1—osteoporosis	1.31e-05	0.000313	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TGFB1—osteoporosis	1.12e-05	0.000268	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ADCY5—osteoporosis	1.07e-05	0.000256	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GPX1—osteoporosis	1.07e-05	0.000255	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MTHFR—osteoporosis	9.87e-06	0.000236	CbGpPWpGaD
Cefazolin—ALB—Metabolism—POMC—osteoporosis	7.89e-06	0.000188	CbGpPWpGaD
